INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

ADVENT CAPITAL MANAGEMENT /DE/'s Holding History (CIK: 0001097278)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 4,000 Value ($000) $4 Avg Close — Range —
Q1 2021
Shares 27,701,000 Value ($000) $22,755 Avg Close — Range —
Q4 2020
Shares 27,397,000 Value ($000) $21,720 Avg Close — Range —
Q3 2020
Shares 28,978,000 Value ($000) $23,479 Avg Close — Range —
Q2 2020
Shares 29,044,000 Value ($000) $21,495 Avg Close — Range —
Q1 2020
Shares 36,111,000 Value ($000) $29,433 Avg Close — Range —
Q4 2019
Shares 44,625,000 Value ($000) $45,282 Avg Close — Range —
Q3 2019
Shares 45,740,000 Value ($000) $39,322 Avg Close — Range —
Q2 2019
Shares 51,245,000 Value ($000) $45,744 Avg Close — Range —
Q1 2019
Shares 51,747,000 Value ($000) $51,281 Avg Close — Range —
Q4 2018
Shares 23,118,000 Value ($000) $21,341 Avg Close — Range —
Q3 2018
Shares 28,863,000 Value ($000) $29,171 Avg Close — Range —
Q2 2018
Shares 25,100,000 Value ($000) $21,948 Avg Close — Range —
Q1 2018
Shares 21,513,000 Value ($000) $17,230 Avg Close — Range —
Q4 2017
Shares 24,415,000 Value ($000) $19,539 Avg Close — Range —
Q3 2017
Shares 24,766,000 Value ($000) $19,323 Avg Close — Range —
Q2 2017
Shares 7,688,000 Value ($000) $7,467 Avg Close — Range —
Q1 2017
Shares 7,823,000 Value ($000) $7,302 Avg Close — Range —
Q4 2016
Shares 9,279,000 Value ($000) $8,330 Avg Close — Range —
Q3 2016
Shares 9,281,000 Value ($000) $10,387 Avg Close — Range —
Q2 2016
Shares 10,000,000 Value ($000) $10,301 Avg Close — Range —